Published on 10 Apr 2024 on Investing.com
Ocugen, Inc. ( NASDAQ : NASDAQ: OCGN ), a biotechnology company specializing in gene and cell therapies and vaccines, today announced a significant...
Start tracking your investments with Statfolio
On September 30, 2024, State Street Corp made a significant addition to its investment portfolio ...
Ocugen Inc (OCGN) extends its financial runway with successful fundraising and regulatory...
The Medical group has plenty of great stocks, but investors should always be looking for companie...
Ocugen, Inc. OCGN is having a phenomenal run in the year so far. Shares of the company have...
Ocugen, Inc. OCGN is likely to provide updates on its pipeline developments when it reports first...
Stockholder Alert: Robbins LLP Informs Investors of the Class Action Filed Against Ocugen, Inc....
Ocugen (OCGN) stock gains as company wins EU nod for a U.S. trial for its gene therapy candidate,...
Ocugen, Inc. ( NASDAQ : NASDAQ: OCGN ), a biotechnology company specializing in gene and cell the...
Ocugen, Inc. OCGN announced that the Data and Safety Monitoring Board (“DSMB”) for the early to m...
Ocugen, Inc. OCGN shares are trading higher Friday after the company announced it has received ap...